All In MedTech

Device Trial Radar · NCT03044054

Treatment of Breast Fibroadenoma Targeted Tissue With HIFU

Treatment of Breast Fibroadenoma Targeted Tissue With High Intensity Focused Ultrasound (HIFU)

Last checked: Nov 20, 2026Latest source record: May 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

113

Actual

Start

Jan 2017

Primary completion

Mar 2026

Study completion Apr 2026

Sponsor

Lead sponsor
TheraclionNot on our public-company list
Sponsor type
Industry
First posted
Feb 6, 2017

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the efficacy and the safety of the HIFU for the treatment of breast fibroadenoma.

Conditions

  • Breast Fibroadenoma

Interventions

  • ECHOPULSEDevice

    HIFU Under ultrasound guidance

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain level assessmentTime frame: 12 Months

2 more outcomes with a free account

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Bellevue Hospital Center

    New York, New York

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.